GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
GUIDED THERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026
- Market cap
- $15.45M
- P/E (TTM)
- –
- Dividend yield
- –
GUIDED THERAPEUTICS INC revenue by segment
By business segment
By product or service
| Revenue | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Major Part Components | $100.00K | $15.00K | – | – | 98.0% | +566.7% |
| Disposables | $2.00K | $2.00K | $32.00K | $54.00K | 2.0% | 0.0% |
| Devices | $0 | $17.00K | $17.00K | $177.00K | 0.0% | -100.0% |
| Warranty | $0 | $2.00K | $7.00K | $10.00K | 0.0% | -100.0% |
| Other | – | $15.00K | $1.00K | $3.00K | – | – |
By region
| Revenue | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| Asia | $102.00K | $22.00K | $49.00K | $288.00K | 100.0% | +363.6% |
| Europe | $0 | $14.00K | $0 | -$14.00K | 0.0% | -100.0% |
| Africa | – | $0 | $8.00K | -$15.00K | – | – |
| North America | – | – | $0 | -$5.00K | – | – |
| South America | – | – | $0 | -$10.00K | – | – |
From the segment and revenue-disaggregation notes of Guided Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.